Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
Gene Therapy00:59

Gene Therapy

4.8K
4.8K
Hearing01:31

Hearing

58.9K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
58.9K
Genetic Lingo01:11

Genetic Lingo

118.2K
Overview
118.2K
Unrenewable Cells00:50

Unrenewable Cells

3.0K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
3.0K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

17.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.

Brain : a journal of neurology·2026
Same author

Aphasic status epilepticus due to Epstein-Barr virus meningoencephalitis - A clinical vignette.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis.

Neurology and therapy·2026
Same author

Generation of marmoset monkeys with a non-mosaic disruption of the OTOF gene as a model of human deafness.

Nature communications·2026
Same author

Dysferlin stabilizes membrane nanodomains of cardiomyocytes after myocardial infarction.

Scientific reports·2026
Same author

Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review.

Neurology and therapy·2026

Related Experiment Video

Updated: Apr 7, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

11.1K

Gene therapy for deafness: How close are we?

Tobias Moser1

  • 1Institute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37099 Göttingen, Germany. Synaptic Nanophysiology Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. Auditory Neuroscience Group, German Primate Center, Göttingen, Germany. Auditory Neuroscience Group, Max Planck Institute for Experimental Medicine, Göttingen, Germany. Collaborative Research Center 889, University of Göttingen, Göttingen, Germany.

Science Translational Medicine
|July 10, 2015
PubMed
Summary

Gene therapy using virus-mediated transfer of TMC1 and TMC2 genes into ear hair cells shows promise for partially restoring hearing in animal models of genetic deafness.

More Related Videos

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

17.5K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.9K

Related Experiment Videos

Last Updated: Apr 7, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

11.1K
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

17.5K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.9K

Area of Science:

  • Oto-genetics and molecular biology
  • Auditory neuroscience
  • Gene therapy applications

Background:

  • Genetic deafness is a significant cause of hearing loss.
  • Mechanotransducer channels, specifically TMC1 and TMC2, are crucial for auditory function.
  • Current treatments for genetic deafness are limited.

Purpose of the Study:

  • To investigate the potential of gene therapy for treating genetic deafness.
  • To assess the efficacy of delivering TMC1 and TMC2 genes to inner ear hair cells.
  • To evaluate the impact of this gene transfer on hearing restoration.

Main Methods:

  • Utilized a virus-mediated gene transfer approach.
  • Targeted inner ear hair cells in animal models of human genetic deafness.
  • Administered genes encoding the mechanotransducer channel candidates TMC1 and TMC2.

Main Results:

  • Partial restoration of hearing was observed in the treated animal models.
  • Successful delivery of TMC1 and TMC2 genes into hair cells was confirmed.
  • The restored hearing function was linked to the expression of the introduced genes.

Conclusions:

  • Virus-mediated gene transfer of TMC1 and TMC2 offers a potential therapeutic strategy for genetic deafness.
  • Targeting mechanotransducer channels in hair cells is a viable approach for hearing restoration.
  • This study provides a foundation for further development of gene therapies for hearing loss.